0001728117-22-000094.txt : 20221027 0001728117-22-000094.hdr.sgml : 20221027 20221027170443 ACCESSION NUMBER: 0001728117-22-000094 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221024 FILED AS OF DATE: 20221027 DATE AS OF CHANGE: 20221027 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carter Laura CENTRAL INDEX KEY: 0001858178 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 221338036 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 wf-form4a_166690466548859.xml FORM 4/A X0306 4/A 2022-10-24 2022-10-25 0 0001728117 Gossamer Bio, Inc. GOSS 0001858178 Carter Laura 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2022-10-24 4 S 0 4876 12.073 D 82292 D The Reporting Person's purchase of 6,934 shares of common stock at a price of $7.21 per share on July 15, 2022 was matchable under Section 16(b) of the Securities Exchange Act of 1934, with the Reporting Person's sale of common stock reported herein and, to the extent of 2,058 shares, the Reporting Person's sale of common stock at a price of $8.278 per share on March 16, 2022. The Reporting Person has agreed top pay to the Issuer $18,558.51, which, together with the $7,351.42 previously paid to the Issuer on July 15, 2022, represents the full amount of the profit realized in connection with the short-swing transaction. Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. This transaction was executed in multiple trades at prices ranging from $11.881 to $12.078 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold.Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. This Form 4 is being amended solely to add new footnote 1 regarding the reporting persons' prior agreement to disgorge short-swing profits to the Issuer. /s/ Jeff Boerneke, Attorney-in-Fact 2022-10-27